Frontiers in Oncology

Contemporary Epidemiology of Hepatocellular Carcinoma in the U.S⁣.

Hashem El-Serag, MD, MPH⁣
Tuesday, December 1, 2020⁣⁣

Dr. El-Serag is the Margaret M. and Albert B. Alkek Professor and Chair Department of Medicine Baylor College of Medicine. His research focuses on the clinical epidemiology and outcomes of several digestive disorders, including Barrett's esophagus, esophageal adenocarcinoma, hepatocellular carcinoma, and hepatitis C. He has obtained >55 funded research grants including those from NIH, VA, and Cancer Prevention Research Institute of Texas (CPRIT). He has >520 published papers to his credit including those published in the New England Journal of Medicine, JAMA, Annals of Internal Medicine, and Gastroenterology. His national leadership roles included Editor-in-Chief for Clinical Gastroenterology and Hepatology(2012-2017) and President of American Gastroenterological Association (2019). Dr. El-Serag’s has been selected into the American Society for Clinical Investigators (ASCI) and the American Association of Physicians (AAP).⁣

Frontiers in Oncology

Frontiers in Oncology, a recurring seminar series organized by the Stanford Cancer Institute, is designed to highlight innovations in cancer research across the spectrum of basic, translational, clinical and population science.  The dynamic speakers represent a broad range of disciplines and expertise from both Stanford faculty and national thought leaders.  The audience for this seminar series includes Stanford faculty, trainees and staff as well as anyone in the broader community with an interest in cancer research.  Each recorded seminar is approximately 1 hour in length.